Vertex Pharmaceuticals (VRTX) Q1 2022 Earnings Report

0 Followers

MX:VRTX Q1 2022 EPS Results

Actual EPS: MXN 65.32
Consensus EPS: MXN 66.23
Beat/Miss: Missed by -MXN 0.91
One Year Ago EPS: MXN 55.30

MX:VRTX Q1 2022 Revenue Results

Actual Revenue: MXN 38.55B
Expected Revenue: MXN 38.50B
Beat/Miss: Beat by +MXN 46.78M
YoY Revenue Growth: +19.33%

Earnings Announcement Details

Quarter: Q1 2022
Date: 05/05/2022
Time: After Close
Conference Call: Thursday, May 5, 2022

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q1 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:VRTX Earnings History

MX:VRTX earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 09, 2027	2026 (Q4)	78.47-	93.34	―	―
Nov 02, 2026	2026 (Q3)	89.3888.33	89.07	-0.83% (-0.74)
Aug 03, 2026	2026 (Q2)	87.9787.77	83.87	4.65% (+3.90)
May 04, 2026	2026 (Q1)	78.7382.95	75.34	10.10% (+7.61)
Feb 12, 2026	2025 (Q4)	94.8493.34	73.85	26.38% (+19.48)
Nov 03, 2025	2025 (Q3)	84.8689.07	81.28	9.59% (+7.79)
Aug 06, 2025	2025 (Q2)	79.5783.87	-238.07	135.23% (+321.95)
May 05, 2025	2025 (Q1)	80.1175.34	88.33	-14.71% (-12.99)
Feb 10, 2025	2024 (Q4)	74.5273.85	77.94	-5.24% (-4.08)
Nov 04, 2024	2024 (Q3)	75.6781.28	75.71	7.35% (+5.57)
Aug 01, 2024	2024 (Q2)	-215.73-238.07	72.18	-429.82% (-310.26)
May 06, 2024	2024 (Q1)	75.5888.33	56.6	56.07% (+31.73)
Feb 05, 2024	2023 (Q4)	75.4777.94	69.77	11.70% (+8.16)
Nov 06, 2023	2023 (Q3)	73.0075.71	74.41	1.75% (+1.30)
Aug 01, 2023	2023 (Q2)	71.6172.18	66.8	8.06% (+5.38)
May 01, 2023	2023 (Q1)	55.9156.60	65.32	-13.35% (-8.72)
Feb 07, 2023	2022 (Q4)	65.5069.77	62.53	11.57% (+7.24)
Oct 27, 2022	2022 (Q3)	67.0474.41	66.06	12.64% (+8.35)
Aug 04, 2022	2022 (Q2)	64.4666.80	57.71	15.76% (+9.09)
May 05, 2022	2022 (Q1)	66.2365.32	55.3	18.12% (+10.02)
Jan 26, 2022	2021 (Q4)	60.9962.53	46.58	34.26% (+15.96)
Nov 02, 2021	2021 (Q3)	57.3466.06	48.99	34.85% (+17.07)
Jul 29, 2021	2021 (Q2)	46.9757.71	48.43	19.16% (+9.28)
Apr 29, 2021	2021 (Q1)	―55.30	47.5	16.41% (+7.79)
Feb 01, 2021	2020 (Q4)	―46.58	31.55	47.65% (+15.03)
Oct 29, 2020	2020 (Q3)	―48.99	22.82	114.63% (+26.16)
Jul 30, 2020	2020 (Q2)	―48.43	23.38	107.14% (+25.05)
Apr 29, 2020	2020 (Q1)	―47.50	21.15	124.56% (+26.35)
Jan 30, 2020	2019 (Q4)	―31.55	24.12	30.77% (+7.42)
Oct 30, 2019	2019 (Q3)	―22.82	20.23	12.84% (+2.60)
Jul 31, 2019	2019 (Q2)	―23.38	17.44	34.04% (+5.94)
Apr 30, 2019	2019 (Q1)	―21.15	14.1	50.00% (+7.05)
Feb 05, 2019	2018 (Q4)	―24.12	11.32	113.11% (+12.80)
Oct 24, 2018	2018 (Q3)	―20.23	9.83	105.66% (+10.39)
Jul 25, 2018	2018 (Q2)	―17.44	7.24	141.03% (+10.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Vertex Pharmaceuticals earnings date